KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Shares: 2015-2018

Historic Preferred Shares for Teva Pharmaceutical Industries (TEVA) over the last 1 years, with Sep 2018 value amounting to $3.8 billion.

  • Teva Pharmaceutical Industries' Preferred Shares was N/A to $3.8 billion in Q3 2018 from the same period last year, while for Sep 2018 it was $3.8 billion, marking a year-over-year change of. This contributed to the annual value of $3.6 billion for FY2017, which is 0.30% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Preferred Shares of $3.8 billion as of Q3 2018, which was up 1.73% from $3.8 billion recorded in Q2 2018.
  • In the past 5 years, Teva Pharmaceutical Industries' Preferred Shares registered a high of $3.8 billion during Q3 2018, and its lowest value of $3.3 billion during Q4 2015.
  • Moreover, its 3-year median value for Preferred Shares was $3.7 billion (2018), whereas its average is $3.7 billion.
  • Data for Teva Pharmaceutical Industries' Preferred Shares shows a peak YoY grew of 10.00% (in 2016) over the last 5 years.
  • Quarterly analysis of 4 years shows Teva Pharmaceutical Industries' Preferred Shares stood at $3.3 billion in 2015, then rose by 10.00% to $3.6 billion in 2016, then rose by 0.30% to $3.6 billion in 2017, then reached $3.8 billion in 2018.
  • Its last three reported values are $3.8 billion in Q3 2018, $3.8 billion for Q2 2018, and $3.7 billion during Q1 2018.